NCT04488094View on ClinicalTrials.gov

Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Graft RejectionHeart TransplantationLiver Transplantation
Interventions
DRUG

[18F]FSPG

A radioactive dose of 200 MBq of the study drug with a total quantity of ≤ 100 µg will be administered as slow intravenous bolus injection over up to 60 seconds. PET/CT examinations will be performed at 60-75 min after the administration of \[18F\]FSPG.

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER